This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Gene'e Tech Co., Ltd.. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
Title: Innovations of Chung-Hao Wang
Introduction
Chung-Hao Wang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical materials and drug delivery systems. With a total of 2 patents, his work focuses on enhancing therapeutic efficacy through innovative solutions.
Latest Patents
Chung-Hao Wang's latest patents include a hemostatic material and a chitosan magnetic particle drug carrier. The hemostatic material patent introduces a preparation method that combines water-insoluble gelatin and hydrating materials to create a product that increases blood absorption capacity. The pharmaceutical composition derived from this hemostatic material includes active pharmaceutical ingredients, making it a valuable tool in medical applications. His second patent involves a drug carrier that utilizes negatively charged polymers, chitosan, and magnetic particles. This innovative drug structure is designed to inhibit specific conditions and demonstrates enhanced therapeutic efficacy.
Career Highlights
Chung-Hao Wang is associated with Gene'e Tech Co., Ltd., where he continues to develop and refine his inventions. His work has the potential to impact various medical fields, particularly in improving patient outcomes through advanced materials and drug delivery systems.
Collaborations
Chung-Hao Wang collaborates with talented individuals such as Shu-Jyuan Yang and Li-Cheng Pan. Their combined expertise contributes to the innovative projects at Gene'e Tech Co., Ltd.
Conclusion
Chung-Hao Wang's contributions to the fields of hemostatic materials and drug delivery systems highlight his role as a significant inventor. His patents reflect a commitment to advancing medical technology and improving therapeutic outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile